Advanced Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Published Medical Literature

Nonmelanoma Skin Cancer: Improving Adherence to NCCN Guidelines for Preferred Treatment
Is Access to Tanning Bed Facilities Linked to Regional Melanoma Rates?
Older Individuals With Cutaneous Malignant Melanoma: 30-Year Trends
Accuracy of Skin Cancer Diagnosis: Focus on Lesion Type, Physician Experience, and Exam Method
Are Cryoablation and Immune Checkpoint Inhibition Synergistic in Metastatic Melanoma?
Use of Cemiplimab for Unresectable Squamous Cell Skin Cancer: Case Report
Safety Lead-in With First-Line Triplet Therapy for Advanced BRAF V600–Mutant Melanoma
Consensus on the Optimal Techniques for Mohs Micrographic Surgery in Melanoma
Germline Genetic Variation and Development of In Situ or Invasive Melanoma
Can Genetics Reveal Modifiable Risk Factors for Skin Cancer?
After PD-1 Inhibitors Fail: Is Ipilimumab an Option for Some With Metastatic Melanoma?
Study Reveals Potential Diagnostic Pitfall in Merkel Cell Carcinoma
Novel Tool May Predict Survival in Stage IV Melanoma After First-Line Immunotherapy
Advanced Melanoma: 10-Year Outcomes With Nivolumab and Ipilimumab Support Earlier Results
Neurologic Symptoms and Immunotherapy for Melanoma Brain Metastases: A View From New Zealand
Use of Cemiplimab in a 90-Year-Old Woman With Skin Cancer: Debunking Age ‘Myths’
Advanced Merkel Cell Carcinoma: Quality of Life With Immunotherapy
Immunotherapy for Melanoma: Can the Presence of Autoantibodies Predict Adverse Events?
Potential Biomarker Under Study in Patients With Rare Skin Disease and Squamous Cell Carcinoma
Basal Cell Carcinoma: Novel Clinical Algorithm May Help to Identify Those at High Risk
LAG-3 and PD-1 Inhibition: Working Together to Activate Immune Responses in Melanoma
Genomic Landscape of Squamous Cell Skin Cancer and Dermal Invasion
Hypoalbuminemia: An Independent Biomarker of Immunotherapy Response in Metastatic Melanoma?
Treating Metastatic Basal Cell Carcinoma With Cemiplimab: Focus on Quality of Life
Adjuvant Immunotherapy in Melanoma: Cell- and Tissue-Specific PD-L1 Expression May Predict Response
Recognizing Practice Patterns and Outcomes of a Rare Type of Skin Cancer
Standardized Guidelines for Retrospective Research in Cutaneous Squamous Cell Carcinoma
Immunotherapy for Merkel Cell Carcinoma: Are Tissue-Resident T Cells Drivers of Response?
Rurality, Race, and Lower Income: Researchers Find All Affect the Incidence of Skin Cancer
Merkel Cell Polyomavirus Serum Antibody Test May Facilitate Enhanced Risk Stratification
Incompletely Excised Basal Cell Carcinoma: Researchers Explore Next Best Steps
Are Patients Being Treated for Psoriasis at Risk for Skin Cancer?
Combination of BRAF and MEK Inhibition for BRAF V600/NRAS Q61 Wild-Type Melanoma
Can Circulating Biomarkers Predict Response to Immunotherapy in Metastatic Melanoma?
Vismodegib Plus Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
KEYNOTE-716 Trial Update: Adjuvant Pembrolizumab in Resected Stage IIB or IIC Melanoma
Do Race and Sex Play a Role in Nonmetastatic Melanoma?
Can New AI Tool Help to Distinguish Melanomas From Benign Skin Lesions? Swedish Researchers Say Yes
Diagnosing Non-Melanoma Skin Cancers: Novel Lipid Sampling Approach Under Study
Risk Prediction Calculator From Australia Under Study in Stage II Melanoma
Genomic Analysis Reveals Basal Cell Carcinoma Loci Across Ethnically Diverse Patient Population
Potential Link Between Smoking and Survival in Early-Stage Primary Melanoma
Second-Generation Vaccine for Melanoma Under Study: Did Men and Women Benefit Equally?
Age-Related Loss of Protein HAPLN1 May Contribute to Metastasis in Melanoma
Researchers Explore Combined Molecular Targeting for Preventing Skin Tumor Growth
Neoadjuvant Cemiplimab-rwlc and Surgery for Skin Cancer Subtype: Follow-up Trial Data
Novel Biomarker: Potential Link to Improved Therapy for Basal and Squamous Cell Carcinomas
Basal Cell Carcinoma: Using AI to Improve Tumor Excision and Patient Results
Three-Pronged Treatment Approach to Advanced Melanoma With BRAF V600 Mutation
Factors Influencing Non-Melanoma Skin Cancer: Trends in Sun Exposure and Comorbidities
Case Series: Features of Melanoma Among Black Patients in Dallas
Intermittent vs Continuous Dosing of Dabrafenib Plus Trametinib in Advanced Melanoma
Giant Advanced Basal Cell Carcinoma in the Axilla Region: Case Report
Cutaneous Squamous Cell Carcinoma: Link Between VEGFC Expression and Tumor Progression?
Basal Cell Carcinoma: Impact of Location of Metastasis on Survival Outcomes
Trends in UV Radiation Exposure and Risk of Non-Melanoma Skin Cancers
High-Frequency Ultrasound: Can It Differentiate Between Basal Cell Carcinoma Subtypes?
Early-Onset Merkel Cell Carcinoma: A New Member of the Family of Heritable Cancers?
Basal Cell Skin Cancer: Updated NCCN Guidelines Focus on Risk Stratification
Skin Cancer Prevention Measures Among Hispanic Individuals in Florida and Puerto Rico
Topical Patches for Non-Melanoma Skin Cancer: Collaboration May Conquer Challenges
Cutaneous Squamous Cell Carcinoma in Recipients of Solid Organ Transplants
Next-Generation, Small-Molecule BRAF Inhibitor Under Study in Skin Cancer
AI-Assisted Color Constancy: A Real-World Benefit in Skin Lesion Assessment?
Non-Melanoma Skin Cancer: Systemic Therapy Before Surgical Excision
Causes of Death in Patients With Cutaneous Squamous Cell Carcinoma: Risk Factors Tell the Story
FLASH Trial: Photodynamic Therapy Active in Early-Stage Cutaneous T-Cell Lymphoma
Skin Cancer on the Face: Case Study of Wide Excision Surgery With Frozen Section
A Profile of Basal Cell Carcinoma in Western Cape, South Africa
Secondary Mutations May Be Key to How Basal Cell Carcinomas Overcome Dormancy
Prevention of Skin Cancer Through Sun Exposure Education in Welsh Primary Schools
Are Military Populations at Increased Risk of Skin Malignancies?
New Findings Link Sonic Hedgehog Pathway Genes to Keratinocyte Cancers
Link Between Risk of Squamous Cell Skin Cancer and Severity of Actinic Keratosis?
Rare Case of Metatypical Basal Cell Carcinoma: Aggressive Nature Warrants Intensive Follow-Up
Diagnostic Utility of Immunohistochemistry for Cutaneous Basaloid Neoplasms
Prognostic Implications of Satellitosis or In-Transit Metastasis in Cutaneous Squamous Cell Carcinoma
Keratinocyte Cancer in Australia: Identifying Trends in Incidence and Risk
Are Solid Organ Transplant Recipients at Increased Risk for Skin Cancer?
MYBL2 and TK1: Biomarkers in Cutaneous Squamous Cell Carcinoma?
Does Exposure to the Kinase Inhibitor Ruxolitinib Increase the Risk of Skin Cancer?
Concordance Between Referral and Expert Diagnosis in Patients With Rare Skin Cancer
Zinc-Based Metal–Organic Frameworks: Potential Platform in Sun Protection?
Is Argon-Helium Cryoablation an Alternative for Older Patients With Unresectable Skin Cancer?
Diagnosis and Treatment of Locally Advanced Basal Cell Carcinoma: A Registry Study
Wounding Therapies and IGF-1/IGF-1R Signaling in Preventing Age-Associated Skin Cancer
Iridium-192 High-Dose–Rate Brachytherapy With Valencia Applicators in Treating Skin Cancer
Are Photoprotection Measures Needed for People of Color?
Digital Pathology Data Set of Skin Cancers Represents Countless Hours of Hand Annotations
Single-Center Experience With Sonidegib in Advanced Basal Cell Carcinoma
Is the Use of Tacrolimus and Pimecrolimus Associated With Risk of Skin Cancer?
Plesiotherapy for Skin Cancer: Customized Molds May Be Key to Success
Antimicrobial Peptides and Basal Cell Carcinoma
Overall Survival With Radiotherapy and Chemotherapy for Merkel Cell Carcinoma
Merkel Cell Carcinoma: Surgical Margin Positivity and Outcomes
Rare Case of Basal Cell Carcinoma Plus Sebaceous Carcinoma After Mohs Surgery
Basal Cell Carcinoma on the Nose Versus Other Sites of the Face: Appropriate Treatment Considerations
Case Report: Elderly Woman Experiences Spontaneous Regression of Merkel Cell Carcinoma
Which Patients With Basal Cell Carcinoma May Be Appropriate Candidates for Watchful Waiting?
Is Skin Cancer Risk Influenced by Vitamin D Serum Levels?
Combining CO2 Laser, Diclofenac, and Imiquimod to Treat Inoperable Basal Cell Carcinoma
Is There a Possible Association Between Psoriasis and Cutaneous Squamous Cell Carcinoma?
Metastatic Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma: Diagnostic Role of Genomic Tumor Sequencing
Interleukin 17A and Skin Cancer: A Potential Therapeutic Target?
Case Study: Potential Link Between JAK Inhibitor and Merkel Cell Carcinoma?
Molecular Profiling to Determine Genetic Variants in Young Patients With Basal Cell Carcinoma
Skin Cancer Following Solid Organ Transplantation and Transcribed HPV Infection
Avelumab in Electrochemotherapy-Resistant Merkel Cell Carcinoma: Case Report
Rare Case of Merkel Cell Carcinoma Associated With CLL
Measuring the Burden of Skin Cancers in the United States: From 1990 to 2019
Case Report: Avelumab Therapy for Metastatic Merkel Cell Carcinoma
Can Vismodegib Therapy Improve Visual Function for Patients With Basal Cell Carcinoma?
Intralesional Treatment of Skin Cancer in Double-Transplant Recipient: Case Report
Skin Cancer and Health-Related Quality of Life: Risk Factors and Patient Education
Expression of TRPM8 Protein in Non-Melanoma Skin Cancer
Skin Cancer Awareness Amid the Coronavirus Pandemic: Focus on Internet Searches
Could ALK Phosphorylation Be Linked to Outcomes in Merkel Cell Carcinoma?
Risk Factors by Skin Cancer Type Among Recipients of Organ Transplants
An Unusual Case of Merkel Cell Carcinoma Metastasis to the Kidneys
Locally Advanced Basal Cell Carcinoma: Use of Cemiplimab-rwlc After Hedgehog Inhibitor Therapy
Is Statin Exposure Associated With Squamous Cell Carcinoma Risk?
Is Paraoxonase-2 a Marker for Cutaneous Neoplasms?
Cutaneous Squamous Cell Carcinoma of the External Lip: 40-Year Trends
Treating Skin Cancers Around the Eye With Interstitial HDR Brachytherapy
Rate of Skin Cancer Diagnoses During COVID-19 Pandemic: Canadian Population Study
UVB-Induced Premalignant Skin Lesions: Novel Role of Dopamine D2 Receptors Identified
Unusual Case Presentation of an Ulcerative Variant of Merkel Cell Carcinoma
Developing a Digitized Deep Learning Model to Detect Basal Cell Carcinoma
Topical Ascorbic Acid Solution for Squamous Cell Carcinoma: Case Study
Case Report: Simultaneous Merkel Cell Carcinoma and Colorectal Cancer
Vismodegib Therapy and Xanthomatous Dermal Changes: Case Study in Basal Cell Carcinoma
Non-Melanoma Skin Cancer Incidence and Chronic Occupational Radiation Exposure
Are HCTZ-Containing Products Associated With Increased Risk of Non-Melanoma Skin Cancers?
Is Intralesional Fluorouracil Effective in Treatment of Cutaneous Squamous Cell Carcinoma?
Dermatoscopic Patterns in Non-Melanoma Skin Cancer
Clinical-Dermoscopic Profile of Infiltrative Basal Cell Carcinoma: A Potential Diagnostic Tool
Topical Tirbanibulin Under Study for the Treatment of Actinic Keratosis
Basosquamous Carcinoma: Shedding Light on a Rare Malignancy
Expression of G6PD: Prognostic Marker for Merkel Cell Carcinoma?
High–Dose-Rate Afterloading Brachytherapy for Basal and Squamous Cell Carcinomas
Intermittent Treatment With Vismodegib in Basal Cell Carcinoma: Pilot Study
Are Patients Treated With TNF-Alpha Antagonists for Inflammatory Bowel Disease at Risk for Skin Cancer?
Toxicity Associated With Concomitant Ruxolitinib and Avelumab in Merkel Cell Carcinoma
Potential Biomarkers of Cutaneous Squamous Cell Carcinoma From Actinic Keratosis
Merkel Cell Carcinoma and Interstitial Lung Disease: Case Report on Use of Pembrolizumab
Periauricular Basal Cell Carcinoma: Distribution and Surgical Treatment
Lifestyle Factors Possibly Associated With Non-Melanoma Skin Cancers
Superficial Brachytherapy for Skin Cancer Lesions on Lower Limbs: Case Report
Factors Affecting Excisional Margin Status of Skin Tumors
Rare Case of Basal Cell Carcinoma From Tattoo Ink
Presence of Immune Checkpoint Markers Identified in Cutaneous Angiosarcoma
Multimodal Therapeutic Approach to Aggressive Merkel Cell Carcinoma: Case Report
Immune Checkpoint Inhibition Among Patients With Dermatologic and Hematologic Cancers
Merkel Cell Carcinoma of the Sinonasal Mucosa: Case Report
Multisite Progression of Merkel Cell Carcinoma and Simultaneous Immune-Related Adverse Events
Evaluating Skin Cancer Risk Among Military Personnel
Iron Deficiency Anemia Associated With Basal Cell Carcinoma: Case Report
Novel Strategy for Treating Premalignant Skin Lesions Under Study
Response to Radiotherapy in Basal Cell Carcinoma: Comparison of Noninvasive Imaging Modalities
Case Study: Malignant Melanoma After Merkel Cell Carcinoma
Case Study: Basal Cell Carcinoma as a Nonhealing Lesion
Japanese Study Explores Risk Factors for Non-Melanoma Skin Cancer
Potential Biomarker Investigated for Merkel Cell Carcinoma
Are Chronic Venous Insufficiency and Basal Cell Carcinoma Connected?
Dermatoscopic Morphology: Predicting Nodular Non-Melanoma Versus Melanoma
Radiotherapy for Merkel Cell Carcinoma: Multidisciplinary Team Approach
Case of Basal Cell Carcinoma: Complications From Self-Treatment With Bloodroot Plant
Skin Cancer in Recipients of Liver and Kidney Transplants: Calcineurin Versus mTOR Inhibitors
Long-Term Outcomes in Surgically Managed Skin Cancer in Transplant Recipients
Biopsy Versus Reflectance Confocal Microscopy in Diagnosis of Basal Cell Carcinoma
Merkel Cell Carcinoma: Do Women Have Better Outcomes Than Men?
Cisplatin Electrochemotherapy for Small Non‐Melanoma Skin Lesions
Antimalaria Drug May Inhibit Virus-Positive Merkel Cell Carcinoma Growth
Multidisciplinary Approaches to Managing Merkel Cell Carcinoma
Skin Cancer Prevention: ASCO Issues Policy Statement
COVID-19 and Non-Melanoma Skin Cancer: Revisiting Hypofractionated Radiotherapy
Multiple Aggregated, Yellow-White Globules: Indicator of Basal Cell Carcinoma?
Non-Melanoma Skin Cancer and COVID-19: Modifications to Current Radiotherapy
Genetic Features of Virus-Positive Versus Virus-Negative Merkel Cell Carcinoma
Genetic Link Between Inflammatory Bowel Disease and Skin Cancer?
International Researchers Reveal Clues to Aggressive Skin Cancers
Finnish Researchers Find Unexpected Features of Recurrent and Metastatic Skin Cancers
Mohs Micrographic Surgery for Facial Skin Cancers: Do Patients Have Realistic Expectations?
Nivolumab Prior to Surgery in Patients With Merkel Cell Carcinoma
Could Non-Melanoma Skin Cancer Be Linked to Exfoliation Glaucoma?
Is Parkinson’s Disease Associated With Development of Skin Cancer?
miR-375 in Merkel Cell Carcinoma: An Intracellular Oncogene?
9-Valent HPV Vaccine in Managing Squamous Cell Carcinoma: Case Report
Early-Onset Basal Cell Carcinoma and Cosmetic Tattoos
Role of Autophagy-Related Gene 7 in Non-Melanoma Skin Cancer
Identifying Squamous Cell Carcinoma With Gold Nanoparticle Technology
Quantitative Proteomics Analysis Yields Insights in Merkel Cell Carcinoma
Potential Biomarker of Response to Vismodegib in Basal Cell Carcinoma
Update on Laser Therapies for Basal Cell Carcinoma
Researchers Identify New RNA Molecule in Growth of Squamous Cell Carcinoma
Pilot Study to Investigate Same-Day Diagnosis and Treatment of Basal Cell Carcinomas
Characterizing Bioenergetics of Basal Cell and Squamous Cell Carcinomas
Use of Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma
Evaluating Risk of Basal Cell Carcinoma Linked to Solar Ultraviolet Exposure
Risk of Internal Malignancies in Patients With Non-Melanoma Skin Cancer
Potential Link Between Psoriasis and Risk of Non-Melanoma Skin Cancer
Detecting Skin Cancer Using a Neural Network Algorithm
Patient Preference for Prevention of Non-Melanoma Skin Cancer After Organ Transplantation
ASTRO Clinical Practice Guideline for Radiation Therapy for Basal Cell and Squamous Cell Skin Cancers
Pilot Study Explores Potential Therapeutic Target for Merkel Cell Carcinoma
Alternative Reconstruction Option for Cutaneous Malignancy
Voriconazole and Development of Squamous Cell Carcinoma: Potential Mechanism Identified
Potential Link Between Kidney Disease and Increased Risk for Cutaneous Squamous Cell Carcinoma
Indoor Tanning: Increased Risk for Cutaneous Squamous Cell Carcinoma?
Do Individuals With Psoriasis Have an Increased Risk of Keratinocyte Cancers?
Cancer-Testis Antigens: Immunotherapy Targets for Merkel Cell Carcinoma?
Pembrolizumab for Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma: A Case Study
Comparison of Cosmesis With Four Treatments for Basal and Squamous Cell Carcinomas
Treatment of Basal Cell Carcinoma With Topical Itraconazole
‘Man With Machine’ Approach to Diagnosing Skin Cancer Lesions
Risk of Non-Melanoma Skin Cancer in Patients With Rare Genodermatosis
Grading of Non-Melanoma Skin Cancers: Mohs Micrographic Surgery vs. Initial Biopsy
Long-Term Outcomes With Mohs Surgery for Cutaneous Squamous Cell Carcinoma
Pembrolizumab Therapy for Inoperable Case of Squamous Cell Carcinoma
Does a Family History of Melanoma Increase the Risk of Keratinocyte Cancers?
Risk Factors for Non-Melanoma Skin Cancers in Recipients of Kidney Transplant
Case Study: Rare Keratoacanthoma and Presence of HPV39
Patterns of Major Surgery for Cutaneous Squamous Cell Carcinoma
Use of Avelumab in Merkel Cell Carcinoma: Linking Early Response With Overall Survival
Meta-analysis of Treatment of Skin Cancers With PD-1/PD-L1 Inhibitors
Quality of Life With Vismodegib Treatment of Non-Melanoma Skin Cancers
Standardized Total Body Skin Exam: Improved Accuracy and Efficiency?
Physicians Versus Machine-Learning Algorithms in Classifying Pigmented Skin Lesions
Factors Affecting Survival for Patients with Advanced Cutaneous Squamous Cell Carcinoma
Does PD-1 Expression Differ by Histology in Cutaneous Squamous Cell Carcinoma?
Treatment Patterns for Canadian Patients With Head and Neck Squamous Cell Carcinoma
Multikinase Inhibitor Shows Activity in Aggressive Subtype of Squamous Cell Carcinoma
Predicting Response to Immunotherapy in Squamous Cell Carcinoma
Link Between Skin Cancer Diagnosis and Health-Care Screening Practices
Molecular Role of Complement C3a in Cutaneous Squamous Cell Cancer
Does Squamous Cell Carcinoma Risk Change With Immunosuppression?
Extremity Nevus Count and Risk of Skin Cancers
Association of Indoor Tanning and Skin Cancer in Canada
Is There an Association Between Skin Cancer and Erectile Dysfunction Medications?
Keratinocyte Carcinoma: Update on Treatment and Prevention
Intermittent Vismodegib Regimen for Locally Advanced Basal Cell Carcinoma
Use of Pembrolizumab in First-Line Treatment of Merkel Cell Carcinoma
Comparing Staging Systems in Cutaneous Squamous Cell Carcinoma
Impact of HLA Antigen Mismatches on Skin Cancer Risk in Transplant Recipients
Use of Cetuximab in Multimodality Treatment of Cutaneous Squamous Cell Carcinoma
Factors Contributing to Recurrence of Invasive Squamous Cell Carcinoma
How BMI Interacts With Sun Exposure and Risk of Non-Melanoma Skin Cancer
Using Immunohistochemical Panel to Differentiate Basal Cell Carcinoma and Trichoepithelioma
Risk Factors of Aggressive Skin Cancer in Recipients of Solid Organ Transplants
Research Points to Certain Genetic Links to Cutaneous Squamous Cell Carcinoma
Organ Transplantation and Degree of Differentiation of Cutaneous Squamous Cell Carcinoma
Risk of New Skin Neoplasms in Patients With History of Skin Cancer
Merkel Cell Carcinoma: Need for Timely Diagnosis and Treatment
Study Sheds Light on Cellular Origin of Merkel Cell Carcinoma
Are Some Transplant Recipients Exposed to Voriconazole at Risk for Skin Cancer?
Impact of Tumor Board Conferences on Treatment of Skin Cancer
Master Transcription Factors in Progression of Squamous Cell Carcinoma
Mohs Surgery for High-Risk Squamous Cell Carcinoma
Could Gentian Violet Be Used to Treat Cutaneous T-Cell Lymphoma?
Comparing Outcomes of Different Basal Cell Carcinoma Treatments
MAVORIC Results Support FDA Approval of Mogamulizumab in Cutaneous C-Cell Lymphoma
Case Study Highlights Novel Concurrent Therapy for Cutaneous Squamous Cell Carcinoma
Impact of Non‐Melanoma Skin Cancers on Patients’ Quality of Life
Update on Nonsurgical Treatments of Non-Melanoma Skin Cancer
Identifying Sentinel Lymph Nodes in Merkel Cell Cancer With Indocyanine Green
Do Frequent Occurrences of Basal Cell Carcinoma Increase Risk for Other Cancers?
Do UVA Nail Lamps Pose Cutaneous Carcinogenic Risk?
Identifying Renal Transplant Patients at Risk for Squamous Cell Carcinoma by DNA Methylation of T Cells
Depth of Follicular Involvement in Invasive Squamous Cell Carcinoma
Does Renal Transplant Rejection Influence Risk of Developing Squamous Cell Carcinoma?
Delayed Skin Reactions Reported With PD-1 Inhibitors
Comparison of Photodynamic Therapies for Active Keratosis
New Guidelines for Treating Metastatic Merkel Cell Carcinoma: Focus on Immunotherapy
Squamous Cell Carcinoma of the Lip: Is There a Difference Between Vermilion vs Cutaneous Involvement?
First-Line Avelumab for Metastatic Merkel Cell Carcinoma
Is There a Link Between Skin Cancers and Alzheimer’s Disease?
AAD Guidelines for Non-Melanoma Skin Cancers
Workplace UV Exposure = Quantifiable Economic Costs
Melanoma Mortality Risk and Nonmelanoma Cancer History: Is There a Connection?


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.